CUBE vs PRLD
CubeSmart (CUBE) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the CUBE and PRLD stock pages for the full models.
Not investment advice.